Launched sales of the drug Grandopam

 Launched sales of the drug Grandopam Grandopam helps to handle anxiety and tension.
Composition of Grandopam, capsules: Tofisopam, 50 mg.

Grandopam is indicated to adults for
- psycho (neurotic) and somatic disorders accompanied with psychic tension, anxiety, vegetative failure, lack of energy and/or motivation, apathy, fatigue, depressed mode;
- vegetative symptoms and excitement in pre-delirious and delirious conditions (syndrome of alcohol withdrawal).

Route od administration
Recommended dose: 1 to 2 capsules 1 to 3 times daily (total daily dose 50 to 300 mg).
In case of irregular intake, 1-2 capsules are acceptable.
Gradual dose increase is not required usually. Start therapy with a necessary dose because the drug is well tolerable, and no activity drop and psychic wakefulness are observed.
Grandopam is indicated to adults as a safe anxiolytic maintaining life quality.
Grandopam is in the market from the middle of December,2023.